| GO ID | Ontology | GO Term | Term Definition |
Proteins |
GO:0071000 | BP | response to magnetism | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a magnetic stimulus. |
TJP1 |
GO:0071001 | CC | U4/U6 snRNP | A ribonucleoprotein complex that contains base-paired U4 and U6 small nuclear RNAs. |
PPIH, SART3 |
GO:0071004 | CC | U2-type prespliceosome | A spliceosomal complex that is formed by association of the 5' splice site with the U1 snRNP, while the branch point sequence is recognized by the U2 snRNP. The prespliceosome includes many proteins in addition to those found in the U1 and U2 snRNPs. Commitment to a given pair of 5' and 3' splice sites occurs at the time of prespliceosome formation. |
PRPF40A, LUC7L3, SNRPC, SNRPB, SNRPN, PRPF39, LUC7L, LSM7, LUC7L2 |
GO:0071006 | CC | U2-type catalytic step 1 spliceosome | A spliceosomal complex that is formed by the displacement of the U1 and U4 snRNPs from the precatalytic spliceosome; the U2, U5 and U6 snRNPs remain associated with the mRNA. This complex, sometimes called the activated spliceosome, is the catalytically active form of the spliceosome, and includes many proteins in addition to those found in the U2, and U5 and U6 snRNPs. |
CWC22, RBM22 |
GO:0071007 | CC | U2-type catalytic step 2 spliceosome | A spliceosomal complex that contains the U2, U5 and U6 snRNPs bound to a splicing intermediate in which the first catalytic cleavage of the 5' splice site has occurred. The precise subunit composition differs significantly from that of the catalytic step 1, or activated, spliceosome, and includes many proteins in addition to those found in the U2, U5 and U6 snRNPs. |
RBM22 |
GO:0071008 | CC | U2-type post-mRNA release spliceosomal complex | A spliceosomal complex that is formed following the release of the spliced product from the post-spliceosomal complex and contains the excised intron and the U2, U5 and U6 snRNPs. |
DHX15, GCFC2 |
GO:0071010 | CC | prespliceosome | A spliceosomal complex that is formed by association of the 5' splice site and the branch point sequence with specific snRNPs. The prespliceosome includes many proteins in addition to those found in the bound snRNPs. Commitment to a given pair of 5' and 3' splice sites occurs at the time of prespliceosome formation. Prespliceosome complexes are not active for splicing, but are instead an early step in the assembly of a spliceosomal complex. |
SNRPC, SNRPD1, SNRPD3, CRNKL1 |
GO:0071011 | CC | precatalytic spliceosome | A spliceosomal complex that is formed by the recruitment of a preassembled U5-containing tri-snRNP to the prespliceosome. Although all 5 snRNPs are present, the precatalytic spliceosome is catalytically inactive. The precatalytic spliceosome includes many proteins in addition to those found in the associated snRNPs. |
PLRG1, SON, SNU13, LSM3, SNRPD1, SNRPD2, SNRPD3, SNRNP35, AGGF1, SNRNP27, PRPF31, SNRNP40, SF3B5, CRNKL1, LSM2, RBMX2, SF3B6 |
GO:0071012 | CC | catalytic step 1 spliceosome | A spliceosomal complex that is formed by the displacement of the two snRNPs from the precatalytic spliceosome; three snRNPs including U5 remain associated with the mRNA. This complex, sometimes called the activated spliceosome, is the catalytically active form of the spliceosome, and includes many proteins in addition to those found in the associated snRNPs. |
CRNKL1 |
GO:0071013 | CC | catalytic step 2 spliceosome | A spliceosomal complex that contains three snRNPs, including U5, bound to a splicing intermediate in which the first catalytic cleavage of the 5' splice site has occurred. The precise subunit composition differs significantly from that of the catalytic step 1, or activated, spliceosome, and includes many proteins in addition to those found in the associated snRNPs. |
HNRNPR, PLRG1, SYNCRIP, HNRNPC, HNRNPA1, SNRPA1, SNRPB, DDX5, HNRNPA2B1, HNRNPH1, RBMX, SKIV2L2, HNRNPA3, HNRNPM, SNRPF, LSM3, SNRPD1, SNRPD2, SNRPD3, SNRPN, HNRNPU, SRSF1, SF3A3, PRPF4B, CWC27, ALYREF, SRRM1, SNRNP40, CDC5L, DDX23, CRNKL1, PNN, DHX35, CWC22, RBM22, CWC15, LSM7, PRPF19, PPIE, SRRM2, LSM2, RBMX2, SF3B6, RBM8A |
GO:0071014 | CC | post-mRNA release spliceosomal complex | A spliceosomal complex that is formed following the release of the spliced product from the post-spliceosomal complex and contains the excised intron and three snRNPs, including U5. |
CRNKL1 |
GO:0071021 | CC | U2-type post-spliceosomal complex | A spliceosomal complex that is formed following the second splicing event and contains the spliced product, the excised intron, and three snRNPs, including U5. |
PRPF18 |
GO:0071025 | BP | RNA surveillance | The set of processes involved in identifying and degrading defective or aberrant RNAs. |
PELO |
GO:0071028 | BP | nuclear mRNA surveillance | The set of processes involved in identifying and degrading defective or aberrant mRNAs within the nucleus. |
DXO, EXOSC9, EXOSC7, EXOSC6, XRN1, EXOSC8, EXOSC4 |
GO:0071034 | BP | CUT catabolic process | The chemical reactions and pathways resulting in the breakdown of cryptic unstable transcripts (CUTs). |
EXOSC2, EXOSC3, DIS3 |
GO:0071035 | BP | nuclear polyadenylation-dependent rRNA catabolic process | The chemical reactions and pathways occurring in the nucleus and resulting in the breakdown of a ribosomal RNA (rRNA) molecule, including RNA fragments released as part of processing the primary transcript into multiple mature rRNA species, initiated by the enzymatic addition of a sequence of adenylyl residues (polyadenylation) at the 3' end the target rRNA. |
EXOSC9, EXOSC2, EXOSC7, EXOSC8, EXOSC3 |
GO:0071038 | BP | nuclear polyadenylation-dependent tRNA catabolic process | The chemical reactions and pathways occurring in the nucleus and resulting in the breakdown of an aberrant or incorrectly modified transfer RNA (tRNA) molecule, initiated by the enzymatic addition of a sequence of adenylyl residues (polyadenylation) at the 3' end the target tRNA. |
EXOSC9, EXOSC2, EXOSC7, EXOSC8, EXOSC3 |
GO:0071042 | BP | nuclear polyadenylation-dependent mRNA catabolic process | The chemical reactions and pathways occurring in the nucleus and resulting in the breakdown of a messenger RNA (mRNA) molecule, initiated by the enzymatic addition of a sequence of adenylyl residues (polyadenylation) at the 3' end the target mRNA. |
EXOSC9, EXOSC7, PNPT1, EXOSC8 |
GO:0071044 | BP | histone mRNA catabolic process | The chemical reactions and pathways resulting in the breakdown of histone messenger RNA (mRNA). |
PAPD4, DCP2, XRN1, PAPD5, EXOSC4, MTPAP |
GO:0071048 | BP | nuclear retention of unspliced pre-mRNA at the site of transcription | The process involved in retention of incorrectly or incompletely spliced pre-mRNA within the nucleus at the site of transcription. |
PRPF18 |
GO:0071049 | BP | nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription | The process involved in retention of mRNAs that have incorrectly formed 3'-ends within the nucleus at the site of transcription. |
EXOSC2, EXOSC3 |
GO:0071051 | BP | polyadenylation-dependent snoRNA 3'-end processing | Any process involved in forming the mature 3' end of a snoRNA molecule linked to prior polyadenylation of the 3'-end of the precursor snoRNA. |
EXOSC2, EXOSC6, EXOSC4, EXOSC3 |
GO:0071062 | CC | alphav-beta3 integrin-vitronectin complex | A protein complex that consists of an alphav-beta3 integrin complex bound to vitronectin. |
VTN, ITGB3, ITGA5 |
GO:0071065 | CC | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex | A protein complex that consists of an alpha9-beta1 integrin complex bound to vascular cell adhesion molecule-1. |
VCAM1, ADAM8 |
GO:0071071 | BP | regulation of phospholipid biosynthetic process | Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of phospholipids. |
IDH1 |
GO:0071072 | BP | negative regulation of phospholipid biosynthetic process | Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of phospholipids. |
SLC27A1 |
GO:0071073 | BP | positive regulation of phospholipid biosynthetic process | Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of phospholipids. |
FABP3 |
GO:0071074 | MF | eukaryotic initiation factor eIF2 binding | Interacting selectively and non-covalently with eukaryotic initiation factor eIF2, a protein complex involved in the initiation of ribosome-mediated translation. |
EIF5 |
GO:0071103 | BP | DNA conformation change | A cellular process that results in a change in the spatial configuration of a DNA molecule. A conformation change can bend DNA, or alter the, twist, writhe, or linking number of a DNA molecule. |
HHEX |
GO:0071104 | BP | response to interleukin-9 | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-9 stimulus. |
JAK3, CITED1 |
GO:0071105 | BP | response to interleukin-11 | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-11 stimulus. |
CITED1 |
GO:0071107 | BP | response to parathyroid hormone | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a parathyroid hormone stimulus. |
PTH, ITGA2, CITED1 |
GO:0071108 | BP | protein K48-linked deubiquitination | A protein deubiquitination process in which a K48-linked ubiquitin chain, i.e. a polymer of ubiquitin formed by linkages between lysine residues at position 48 of the ubiquitin monomers, is removed from a protein. |
USP27X, TNFAIP3, ATXN3, OTUD7B, USP34, BAP1, OTUB2, OTUB1, VCPIP1, USP25, USP20 |
GO:0071109 | BP | superior temporal gyrus development | The process whose specific outcome is the progression of the superior temporal gyrus over time, from its formation to the mature structure. The superior temporal gyrus is a portion of the cerebral cortex that extends from the lateral sulcus to the superior temporal sulcus. |
GSK3B |
GO:0071133 | CC | alpha9-beta1 integrin-ADAM8 complex | A protein complex that consists of an alpha9-beta1 integrin complex bound to the transmembrane metallopeptidase ADAM8. |
ADAM8 |
GO:0071139 | BP | resolution of recombination intermediates | The cleavage and rejoining of intermediates, such as Holliday junctions, formed during DNA recombination to produce two intact molecules in which genetic material has been exchanged. |
SMC5, SMC6 |
GO:0071141 | CC | SMAD protein complex | A protein complex that consists of SMAD proteins; may be homomeric or heteromeric. |
SMAD9, HMGA2, SMAD3, SMAD4, SMAD2, SMAD1, SMAD5 |
GO:0071144 | CC | SMAD2-SMAD3 protein complex | A heteromeric SMAD protein complex that contains SMAD2 and SMAD3. |
SMAD3, SMAD2 |
GO:0071156 | BP | regulation of cell cycle arrest | Any process that modulates the rate, frequency, or extent of cell cycle arrest, the process in which the cell cycle is halted during one of the normal phases. |
BIN1, AKT2, CDK5, FOXM1 |
GO:0071157 | BP | negative regulation of cell cycle arrest | Any process that decreases the rate, frequency, or extent of cell cycle arrest, the process in which the cell cycle is halted during one of the normal phases. |
MDM4, CDK4, MIF, MDM2, ZNF268, GPER1 |
GO:0071158 | BP | positive regulation of cell cycle arrest | Any process that increases the rate, frequency, or extent of cell cycle arrest, the process in which the cell cycle is halted during one of the normal phases. |
TGFB1, TP53, PRKACA, BRCA1, HMGA2, FOXO4, INSM1, ID2, PKD2, PPP2R5B, CRLF3, GATA6, UHRF2, MYBBP1A, RGCC |
GO:0071159 | CC | NF-kappaB complex | A protein complex that consists of a homo- or heterodimer of members of a family of structurally related proteins that contain a conserved N-terminal region called the Rel homology domain (RHD). In the nucleus, NF-kappaB complexes act as transcription factors. In unstimulated cells, NF-kappaB dimers are sequestered in the cytoplasm by IkappaB monomers; signals that induce NF-kappaB activity cause degradation of IkappaB, allowing NF-kappaB dimers to translocate to the nucleus and induce gene expression. |
RELA |
GO:0071166 | BP | ribonucleoprotein complex localization | Any process in which a ribonucleoprotein complex is transported to, or maintained in, a specific location within a cell. |
PRPF31 |
GO:0071168 | BP | protein localization to chromatin | Any process in which a protein is transported to, or maintained at, a part of a chromosome that is organized into chromatin. |
RAD21, ESR1, PLK1, EZH2, ESCO2, WAPL |
GO:0071169 | BP | establishment of protein localization to chromatin | The directed movement of a protein to a part of a chromosome that is organized into chromatin. |
H2AFY, SGF29, H2AFY2, LRWD1, RUVBL2 |
GO:0071171 | BP | site-specific DNA replication termination at RTS1 barrier | A DNA replication termination process that takes place at the RTS1 termination site in the mating type locus, in a specific direction required for subsequent imprinting and mating-type switching. |
RTFDC1 |
GO:0071173 | BP | spindle assembly checkpoint | A cell cycle checkpoint that delays the metaphase/anaphase transition until the spindle is correctly assembled and chromosomes are attached to the spindle. |
BUB1, BUB3, CASC5 |
GO:0071203 | CC | WASH complex | A protein complex that localizes at the surface of endosomes, where it recruits and activates the Arp2/3 complex to induce actin polymerization. In human, the WASH complex is composed of F-actin-capping protein subunits alpha and beta, WASH1, FAM21, KIAA1033, KIAA0196 and CCDC53. |
WASH1, CAPZB, CAPZA1, CCDC53 |
GO:0071204 | CC | histone pre-mRNA 3'end processing complex | A ribonucleoprotein that binds to specific sites in, and is required for cleavage of, the 3'-end of histone pre-mRNAs. The complex contains the U7 snRNP and additional proteins, including the stem-loop binding protein (SLBP) and the exonuclease 3'hExo/Eri-1. |
SYNCRIP, SNRPB, YBX1, SLBP |
GO:0071205 | BP | protein localization to juxtaparanode region of axon | Any process in which a protein is transported to, or maintained at, the juxtaparanode region of an axon. |
EPB41L3 |
GO:0071207 | MF | histone pre-mRNA stem-loop binding | Interacting selectively and non-covalently with a conserved stem-loop structure found in histone pre-mRNAs. |
SLBP |
GO:0071208 | MF | histone pre-mRNA DCP binding | Interacting selectively and non-covalently with the downstream cleavage product (DCP) generated by histone pre-mRNA 3'-end processing. |
SNRPB, SNRPD3, SLBP |
GO:0071209 | MF | U7 snRNA binding | Interacting selectively and non-covalently with the U7 small nuclear RNA (U7 snRNA). |
SNRPD3 |
GO:0071218 | BP | cellular response to misfolded protein | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a misfolded protein stimulus. |
ATXN3, UBE2W, HDAC6, STUB1 |
GO:0071219 | BP | cellular response to molecule of bacterial origin | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus by molecules of bacterial origin such as peptides derived from bacterial flagellin. |
SIRT2 |
GO:0071221 | BP | cellular response to bacterial lipopeptide | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a bacterial lipopeptide stimulus. |
TLR2, TIRAP |
GO:0071222 | BP | cellular response to lipopolysaccharide | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria. |
TLR4, TLR5, ABCA1, ASS1, SERPINE1, IL6, ICAM1, CD14, GSTP1, CXCL8, TFPI, CCL2, CD36, CEBPB, XBP1, NFKB1, TNFRSF1B, NR1D1, TNFAIP3, IL10, MRC1, TNFSF4, HMGB2, ZFP36, IL12A, TSPO, WNT5A, MAPK8, STAR, B2M, CCL20, HAMP, HSF1, PPARD, RELA, MEF2C, PDE4D, NR1H3, ADAM9, ANKRD1, MAPK14, CMPK2, PABPN1, LILRB1, NR1H4, LITAF, VIMP, SPON2, CDK19, CXCL16, PLSCR4, NFKBIL1, PPARGC1A, SHPK, PYCARD, HDAC5 |
GO:0071223 | BP | cellular response to lipoteichoic acid | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipoteichoic acid stimulus; lipoteichoic acid is a major component of the cell wall of gram-positive bacteria and typically consists of a chain of glycerol-phosphate repeating units linked to a glycolipid anchor. |
TLR4, RIPK2, TLR2, CD14, CD36, TIRAP, CCL20 |
GO:0071224 | BP | cellular response to peptidoglycan | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a peptidoglycan stimulus. Peptidoglycan is a bacterial cell wall macromolecule. |
RIPK2 |
GO:0071225 | BP | cellular response to muramyl dipeptide | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a muramyl dipeptide stimulus. Muramyl dipeptide is derived from peptidoglycan. |
RIPK2, ARHGEF2, PTPN22 |
GO:0071226 | BP | cellular response to molecule of fungal origin | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus by molecules of fungal origin such as chito-octamer oligosaccharide. |
SYK, CLEC7A |
GO:0071228 | BP | cellular response to tumor cell | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a tumor cell. |
TXNIP |
GO:0071230 | BP | cellular response to amino acid stimulus | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an amino acid stimulus. An amino acid is a carboxylic acids containing one or more amino groups. |
IPO5, SOCS1, EGFR, ASS1, TNF, COL1A1, COL3A1, COL5A2, COL1A2, MMP2, COL6A1, CEBPB, XBP1, DNMT1, ZEB1, SESN2, SESN3, COL16A1, HNRNPD, NTRK2, CPEB4, LAMTOR1, NSMF, SLC38A9, CPEB3, PDGFD, RRAGC, RRAGD, PDGFC, SH3BP4, LAMTOR3, LAMTOR2, SESN1 |
GO:0071231 | BP | cellular response to folic acid | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a folic acid stimulus. |
FOLR1 |
GO:0071233 | BP | cellular response to leucine | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a leucine stimulus. |
SESN2, UBR1 |
GO:0071236 | BP | cellular response to antibiotic | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an antibiotic stimulus. An antibiotic is a chemical substance produced by a microorganism which has the capacity to inhibit the growth of or to kill other microorganisms. |
HSPA5, CDKN1B, PLA2G4A, STAR, MDM2 |
GO:0071242 | BP | cellular response to ammonium ion | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ammonium ion stimulus. |
ASS1 |
GO:0071243 | BP | cellular response to arsenic-containing substance | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an arsenic stimulus from compounds containing arsenic, including arsenates, arsenites, and arsenides. |
DDX3X, HMOX1, PPIF, GSTO1, CPEB2, GSTO2, MKNK2 |
GO:0071247 | BP | cellular response to chromate | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a chromate stimulus. |
BAD |
GO:0071248 | BP | cellular response to metal ion | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a metal ion stimulus. |
HSD17B1 |
GO:0071250 | BP | cellular response to nitrite | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nitrate stimulus. |
PPARGC1A |
GO:0071253 | MF | connexin binding | Interacting selectively and non-covalently with a connexin, any of a group of related proteins that assemble to form gap junctions. |
GJA1, GJA5, CXADR, CNST |
GO:0071257 | BP | cellular response to electrical stimulus | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an electrical stimulus. |
ADSS, NSMF, ADSSL1 |
GO:0071258 | BP | cellular response to gravity | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a gravitational stimulus. |
PTAFR |
GO:0071259 | BP | cellular response to magnetism | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a magnetic stimulus. |
ASCL1 |
GO:0071260 | BP | cellular response to mechanical stimulus | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus. |
TLR4, CHEK1, TLR3, TLR5, BCL10, EGFR, AGT, TGFB1, IL1B, COL1A1, IRF1, ITGA2, GJA1, NFKB1, MAG, BMP6, GADD45A, FAS, MAPK3, TNFRSF8, CASP1, AKT1, PTGS2, PTGER4, LTBR, MAPK8, SOX9, GCLC, ATP1A2, HDAC4, MTPN, RAC1, CRADD, BNIP3, FADD, CASP8, ANKRD1, HABP4, BAD |
GO:0071264 | BP | positive regulation of translational initiation in response to starvation | Any process that activates or increases the frequency, rate or extent of translation initiation, as a result of deprivation of nourishment. |
EIF2AK4, IMPACT |
GO:0071266 | BP | de novo' L-methionine biosynthetic process | The chemical reactions and pathways resulting in the formation of L-methionine, the L-enantiomer of (2S)-2-amino-4-(methylsulfanyl)butanoic acid, from simpler components. |
CTH |
GO:0071268 | BP | homocysteine biosynthetic process | The chemical reactions and pathways resulting in the formation of homocysteine, 2-amino-4-sulfanylbutanoic acid. |
AHCY |
GO:0071276 | BP | cellular response to cadmium ion | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cadmium (Cd) ion stimulus. |
MT1E, MT1F, CYBB, HMOX1, MT1G, MT3, AKR1C3, STAR, MT1H, MT1X |
GO:0071277 | BP | cellular response to calcium ion | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a calcium ion stimulus. |
RASA4, FOS, EDN1, JUN, ALOX15, JUNB, JUND, CAPN3, SYT1, PPIF, FUS, WNT5A, AKR1C3, IQGAP1, FOSB, GPLD1, MEF2A, MEF2C, CAMK2D, RYR3, RASGRP2, CPNE2, SLC25A23, ECT2, CACYBP |
GO:0071279 | BP | cellular response to cobalt ion | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cobalt ion stimulus. |
SERPINF1, BNIP3 |
GO:0071280 | BP | cellular response to copper ion | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a copper ion stimulus. |
PRNP, MT1G, SNCA, AQP2 |
GO:0071281 | BP | cellular response to iron ion | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an iron ion stimulus. |
TF, BMP6, B2M, HFE, TFR2 |
GO:0071283 | BP | cellular response to iron(III) ion | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an iron(III) ion stimulus. |
CCNB1 |
GO:0071284 | BP | cellular response to lead ion | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lead ion stimulus. |
ALAD |
GO:0071285 | BP | cellular response to lithium ion | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lithium (Li+) ion stimulus. |
FABP4, FAS, CALR, CDKN1B, ID2, XRCC4, NFATC4, TPH2 |
GO:0071286 | BP | cellular response to magnesium ion | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a magnesium ion stimulus. |
FBP1, KCNA1, ANK3, RYR3 |
GO:0071287 | BP | cellular response to manganese ion | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a manganese ion stimulus. |
PARK2, TH, HSPA5, ATP13A2 |
GO:0071288 | BP | cellular response to mercury ion | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mercury ion stimulus. |
AQP2 |
GO:0071294 | BP | cellular response to zinc ion | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a zinc ion stimulus. |
KCNK3, MT2A, MT1E, MT1F, PARP1, MT1G, CREB1, TSPO, MT1H, MT1X, ZNF658, MT1M, ATP13A2 |
GO:0071298 | BP | cellular response to L-ascorbic acid | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an L-ascorbic acid (vitamin C) stimulus. |
LEP |
GO:0071300 | BP | cellular response to retinoic acid | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a retinoic acid stimulus. |
OGT, HOXA2, TBX1, KLF4, BRINP1, FZD7, ALDH1A2, ABCA1, COL1A1, LYN, WNT2, CCL2, KRT13, TNC, EPHA3, LTK, PCK1, SERPINF1, PPARG, LEP, WNT5A, ABL2, YAP1, SOX9, WNT3, MEF2C, PTK7, TEAD2, TWF2, ADNP2, SETX, KMT2E, OSR1, HDAC2, WNT5B, CYP26B1, NDUFA13, FZD4, WNT6 |
GO:0071301 | BP | cellular response to vitamin B1 | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin B1 stimulus. |
MDM2 |
GO:0071305 | BP | cellular response to vitamin D | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin D stimulus. |
PENK, BGLAP, ATP2B1, TNC, SFRP1 |
GO:0071306 | BP | cellular response to vitamin E | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin E stimulus. |
COL1A1, PPARG |
GO:0071307 | BP | cellular response to vitamin K | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin K stimulus. |
GAS6, POSTN |
GO:0071310 | BP | cellular response to organic substance | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic substance stimulus. |
IL1B, CLEC3B, PSAP, BCL2, EGR2, CASP1, CD68, TIMP3, IQGAP3 |
GO:0071312 | BP | cellular response to alkaloid | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an alkaloid stimulus. Alkaloids are a large group of nitrogenous substances found in naturally in plants, many of which have extracts that are pharmacologically active. |
ICAM1, STAR, MDM2, TRPV1 |
GO:0071313 | BP | cellular response to caffeine | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a caffeine stimulus. Caffeine is an alkaloid found in numerous plant species, where it acts as a natural pesticide that paralyzes and kills certain insects feeding upon them. |
GSTM2, RYR3, RYR2, SEPN1, PPARGC1A |